DK1448221T3 - Injektionsoplösning af en LHRH antagonist - Google Patents

Injektionsoplösning af en LHRH antagonist

Info

Publication number
DK1448221T3
DK1448221T3 DK02790384T DK02790384T DK1448221T3 DK 1448221 T3 DK1448221 T3 DK 1448221T3 DK 02790384 T DK02790384 T DK 02790384T DK 02790384 T DK02790384 T DK 02790384T DK 1448221 T3 DK1448221 T3 DK 1448221T3
Authority
DK
Denmark
Prior art keywords
injection solution
lhrh antagonist
lhrh
antagonist
injection
Prior art date
Application number
DK02790384T
Other languages
Danish (da)
English (en)
Inventor
Juergen Engel
Werner Sarlikiotis
Horst Bauer
Matthias Rischer
Frank Guethlein
Stefano Dominique Di
Original Assignee
Zentaris Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zentaris Gmbh filed Critical Zentaris Gmbh
Application granted granted Critical
Publication of DK1448221T3 publication Critical patent/DK1448221T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/36—Antigestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
DK02790384T 2001-11-26 2002-11-15 Injektionsoplösning af en LHRH antagonist DK1448221T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10157628A DE10157628A1 (de) 2001-11-26 2001-11-26 Injektionslösung eines LHRH-Antagonisten
PCT/EP2002/012798 WO2003045419A1 (fr) 2001-11-26 2002-11-15 Solution pour injection d'un antagoniste lhrh

Publications (1)

Publication Number Publication Date
DK1448221T3 true DK1448221T3 (da) 2007-03-19

Family

ID=7706799

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02790384T DK1448221T3 (da) 2001-11-26 2002-11-15 Injektionsoplösning af en LHRH antagonist

Country Status (32)

Country Link
EP (1) EP1448221B1 (fr)
JP (1) JP4343693B2 (fr)
KR (1) KR100936636B1 (fr)
CN (1) CN100404068C (fr)
AR (1) AR037424A1 (fr)
AT (1) ATE350050T1 (fr)
AU (1) AU2002365504B2 (fr)
BR (1) BRPI0214412B8 (fr)
CO (1) CO5580793A2 (fr)
CY (1) CY1106401T1 (fr)
DE (2) DE10157628A1 (fr)
DK (1) DK1448221T3 (fr)
EA (1) EA010787B1 (fr)
ES (1) ES2276970T3 (fr)
GE (1) GEP20063861B (fr)
HR (1) HRP20040587B1 (fr)
HU (1) HU230992B1 (fr)
IL (2) IL161894A0 (fr)
IS (1) IS2725B (fr)
ME (1) ME00499B (fr)
MX (1) MXPA04005018A (fr)
NO (1) NO333364B1 (fr)
NZ (1) NZ533712A (fr)
PL (1) PL206199B1 (fr)
PT (1) PT1448221E (fr)
RS (1) RS51408B (fr)
RU (1) RU2322969C2 (fr)
SI (1) SI1448221T1 (fr)
TW (1) TWI312283B (fr)
UA (1) UA81612C2 (fr)
WO (1) WO2003045419A1 (fr)
ZA (1) ZA200404051B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8119159B2 (en) 1999-02-22 2012-02-21 Merrion Research Iii Limited Solid oral dosage form containing an enhancer
US7658938B2 (en) 1999-02-22 2010-02-09 Merrion Reasearch III Limited Solid oral dosage form containing an enhancer
BRPI0710503A2 (pt) 2006-04-07 2011-08-16 Merrion Res Iii Ltd uso de uma composição farmacêutica, composição farmacêutica, e, forma de dosagem oral
RU2517135C2 (ru) * 2008-05-07 2014-05-27 Меррион Рисерч Iii Лимитед Композиции пептидов и способы их получения
US9089484B2 (en) 2010-03-26 2015-07-28 Merrion Research Iii Limited Pharmaceutical compositions of selective factor Xa inhibitors for oral administration
KR20140026354A (ko) 2011-01-07 2014-03-05 메리온 리서치 Ⅲ 리미티드 경구 투여용 철의 제약 조성물
CN103690560B (zh) * 2013-12-17 2016-08-17 辽宁海思科制药有限公司 一种转化糖电解质注射液药物组合物及其制备方法
JP7211704B2 (ja) 2015-01-29 2023-01-24 ノヴォ ノルディスク アー／エス Ｇｌｐ－１アゴニスト及び腸溶コーティングを含む錠剤
RU2614234C2 (ru) * 2015-03-31 2017-03-23 Федеральное государственное бюджетное учреждение науки Институт общей генетики им. Н.И. Вавилова Российской академии наук (ИОГЕН РАН) Фармацевтическая композиция на основе 3-(4-Метилимидазол-1-ил)имидазо[1,2-b][1,2,4,5]тетразина в качестве противоопухолевого средства
BR112019014192A2 (pt) * 2017-01-30 2020-02-11 Antev Limited Composição compreendendo pelo menos um antagonista de gnrh
EP3811927B8 (fr) 2019-10-24 2022-02-23 Sun Pharmaceutical Industries Ltd Forme posologique parentérale stable d'acétate de cétrorélix

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4800191A (en) * 1987-07-17 1989-01-24 Schally Andrew Victor LHRH antagonists
US5140009A (en) * 1988-02-10 1992-08-18 Tap Pharmaceuticals, Inc. Octapeptide LHRH antagonists
US5300492A (en) * 1988-02-10 1994-04-05 Tap Pharmaceuticals LHRH analogs
DE4305225A1 (de) * 1993-02-19 1994-08-25 Asta Medica Ag Neues Herstellverfahren für Cetrorelix Lyophilisat
AU769482B2 (en) * 1999-09-23 2004-01-29 Zentaris Gmbh Method for the therapeutic management of extrauterine proliferation of endometrial tissue, chronic pelvic pain and fallopian tube obstruction
DE10024451A1 (de) * 2000-05-18 2001-11-29 Asta Medica Ag Pharmazeutische Darreichungsform für Peptide, Verfahren zu deren Herstellung und Verwendung

Also Published As

Publication number Publication date
CY1106401T1 (el) 2011-10-12
RU2004119821A (ru) 2005-04-20
GEP20063861B (en) 2006-06-26
KR100936636B1 (ko) 2010-01-14
IL161894A (en) 2014-05-28
RU2322969C2 (ru) 2008-04-27
RS44904A (sr) 2006-10-27
HRP20040587B1 (en) 2008-01-31
PL369548A1 (en) 2005-05-02
AR037424A1 (es) 2004-11-10
BRPI0214412B8 (pt) 2021-05-25
EP1448221B1 (fr) 2007-01-03
EP1448221A1 (fr) 2004-08-25
KR20040058312A (ko) 2004-07-03
AU2002365504A1 (en) 2003-06-10
EA010787B1 (ru) 2008-10-30
ATE350050T1 (de) 2007-01-15
EA200400742A1 (ru) 2004-12-30
HU230992B1 (hu) 2019-08-28
HUP0401986A3 (en) 2012-09-28
CN100404068C (zh) 2008-07-23
TWI312283B (en) 2009-07-21
CN1592630A (zh) 2005-03-09
BR0214412A (pt) 2004-09-14
UA81612C2 (ru) 2008-01-25
SI1448221T1 (sl) 2007-06-30
CO5580793A2 (es) 2005-11-30
JP4343693B2 (ja) 2009-10-14
TW200300352A (en) 2003-06-01
HRP20040587A2 (en) 2004-10-31
IL161894A0 (en) 2005-11-20
BRPI0214412B1 (pt) 2016-01-05
PT1448221E (pt) 2007-03-30
MXPA04005018A (es) 2004-08-11
ZA200404051B (en) 2005-05-25
ES2276970T3 (es) 2007-07-01
WO2003045419A1 (fr) 2003-06-05
DE10157628A1 (de) 2003-06-12
IS2725B (is) 2011-03-15
NZ533712A (en) 2006-01-27
ME00499B (fr) 2011-10-10
IS7251A (is) 2004-05-06
PL206199B1 (pl) 2010-07-30
HK1073078A1 (zh) 2005-09-23
DE50209193D1 (de) 2007-02-15
AU2002365504B2 (en) 2007-06-28
JP2005510544A (ja) 2005-04-21
NO20042449L (no) 2004-06-11
HUP0401986A2 (hu) 2005-01-28
RS51408B (sr) 2011-02-28
NO333364B1 (no) 2013-05-13

Similar Documents

Publication Publication Date Title
DK1438306T3 (da) Derivater af UK-2A
DE60222245D1 (de) Spritzvorrichtung
DK1360169T3 (da) Succinatsalt af O-desmethyl-venlafaxin
DK1443992T3 (da) Sammenklappelig spröjteindsats
DE50213435D1 (de) Brennstoffeinspritzventil-zündkerze-kombination
DE50212586D1 (de) Brennstoffeinspritzventil-zündkerze-kombination
DE50112588D1 (de) Einspritzdüse
DE50211785D1 (de) Brennstoffeinspritzsystem
DE50214553D1 (de) Brennstoffeinspritzsystem
FI20012483L (fi) MOSFETn avulla toteutettu polariteettisuoja
DK1274427T3 (da) Formulering af substituerede benzimidazoler
DK1448221T3 (da) Injektionsoplösning af en LHRH antagonist
DE60217655D1 (de) Injektionsvorrichtung
ATE374183T1 (de) Nk1-antagonisten
DE602004015504D1 (de) Von injektionspräparaten
DE50206023D1 (de) Brennstoffeinspritzanlage
DE50107401D1 (de) Einspritzdüse
DE50103958D1 (de) Einspritzsystem
IS6620A (is) Nýr fjölgervingur V af tórasemíði
DE50210240D1 (de) Brennstoffeinspritzsystem
DK1309607T3 (da) Fremgangsmåde til fremstilling af LHRH-antagonister
FR2811378B1 (fr) Injecteur
DE10111783B4 (de) Einspritzdüse
DE50112538D1 (de) Einspritzanlage
DE50211807D1 (de) Schiebernadel